Trastuzumab Deruxtecan
Products in Health Canada’s databases that list Trastuzumab Deruxtecan as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 1
- 1 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 14
- Products in all
- 1
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| ENHERTU (100 MG)Astrazeneca Canada Inc · Status since Jul 2021 | 02514400 | Marketed | Astrazeneca Canada Inc |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- ENHERTUSeptember 17, 2026 · NOC 38306
- ENHERTUAugust 27, 2026 · NOC 38183
- ENHERTUMay 26, 2026 · NOC 37607
- ENHERTUOctober 27, 2025 · NOC 36272
- ENHERTUJuly 3, 2025 · NOC 35646
- ENHERTUApril 4, 2025 · NOC 35200
- ENHERTUJanuary 17, 2025 · NOC 34717
- ENHERTUJuly 9, 2024 · NOC 33613
- ENHERTUApril 10, 2024 · NOC 33035
- ENHERTUJanuary 6, 2023 · NOC 29859
- ENHERTUDecember 22, 2022 · NOC 29765
- ENHERTUJune 15, 2022 · NOC 28404
- ENHERTUNovember 19, 2021 · NOC 27070
- ENHERTUApril 15, 2021 · NOC 25694